Genpact Vs. Bright Minds Biosciences Industry Stock Comparison

Buy

54

G
Genpact

Last Price:

46.13

Seasonality Move:

4.41%

Sell

25

DRUG
Bright Minds Biosciences

Last Price:

43.34

Seasonality Move:

-15.89%

Buy

54

Genpact (G) is a Buy

Is Genpact a Buy, Sell or Hold?

The current Genpact [G] share price is $46.16. The Score for G is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
G is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

25

Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

The current Bright Minds Biosciences [DRUG] share price is $44.00. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

G Stock Price Chart

What is Genpact's stock price today?

The Genpact share price today is $46.16
The current trend is moderately bullish and G is experiencing selling pressure, which indicates risk of future bearish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

The Bright Minds Biosciences share price today is $44.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

G Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.74	Buy
Relative Strength Index (14 RSI):	69.16	Buy
Chaikin Money Flow:	-553831	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(39.6 - 46.54)	Buy
Bollinger Bands (100):	(34.85 - 42.45)	Buy

DRUG Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.5	Buy
Relative Strength Index (14 RSI):	58.93	Buy
Chaikin Money Flow:	115403	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(37.12 - 49.42)	Buy
Bollinger Bands (100):	(-5.11 - 34.85)	Buy

G Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	45.9	Buy
20-day SMA:	44.27	Buy
50-day SMA:	41.01	Buy
200-day SMA:	35.74	Buy
8-day EMA:	45.96	Buy
20-day EMA:	44.38	Buy
50-day EMA:	41.78	Buy
200-day EMA:	37.61	Buy

DRUG Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	37.17	Buy
20-day SMA:	42.3	Buy
50-day SMA:	28.61	Buy
200-day SMA:	8.06	Buy
8-day EMA:	39.27	Buy
20-day EMA:	39.13	Buy
50-day EMA:	31.07	Buy
200-day EMA:	12.97	Buy

Genpact Earnings Growth & G Earnings Dates

Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.22 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Genpact Technical Analysis

	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22	Nov 25	Nov 26	Nov 27	Nov 29
	Nov
	15	18	19	20	21	22	25	26	27	29
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22	Nov 25	Nov 26	Nov 27	Nov 29
	Nov
	15	18	19	20	21	22	25	26	27	29
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):